Long time response with chemotherapy in ROS1 NSCLC patient with unusual metastatic site

During the last decade the therapeutic landscape of Non Small Cell Lung Cancer (NSCLC) has profoundly changed with the identification of actionable genetic alterations that defined molecularly selected subgroups of patients with specific clinic-pathological characteristics and increased sensitivity...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cancer Biol Ther
Autores principales: Franchina, Tindara, Russo, Alessandro, Ricciardi, Giuseppina Rosaria, Liguori, Giuseppina, Herberg, Astrid, Normanno, Nicola, Adamo, Vincenzo
Formato: Artigo
Lenguaje:Inglês
Publicado: Taylor & Francis 2016
Materias:
Research Paper
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5079394/
https://ncbi.nlm.nih.gov/pubmed/27611848
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2016.1219822
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares